Related Experiment Video
Updated: May 5, 2026

Measuring Post-Stroke Cerebral Edema, Infarct Zone and Blood-Brain Barrier Breakdown in a Single Set of Rodent Brain Samples
Published on: October 23, 2020
The Molecular Mechanisms that Promote Edema After Intracerebral Hemorrhage
Daniel Bodmer1, Kerry A Vaughan, Brad E Zacharia
1Department of Neurological Surgery, The Neurological Institute, Columbia University College of Physicians and Surgeons, New York, NY, 10032, USA.
Insights
Intracerebral hemorrhage (ICH) causes brain swelling and damage. Understanding key molecular pathways like coagulation, inflammation, and hemoglobin toxicity may lead to new treatments for this severe stroke.
Area of Science:
- Neuroscience
- Pathology
- Pharmacology
Background:
- Intracerebral hemorrhage (ICH) is a severe stroke with limited therapeutic options.
- Cerebral edema significantly contributes to secondary brain injury and poor outcomes following ICH.
- Molecular mechanisms driving edema formation after ICH are not fully understood.
Purpose of the Study:
- To review the key signaling pathways implicated in edema formation after ICH.
- To discuss the experimental evidence supporting the role of these pathways in ICH-induced edema.
- To identify potential therapeutic targets for reducing edema in ICH patients.
Main Methods:
- Review of existing literature on molecular pathways involved in ICH.
- Analysis of experimental evidence linking specific pathways to edema formation.
- Identification of potential pharmacological targets based on pathway mechanisms.
Main Results:
- The coagulation cascade/thrombin, inflammatory response/matrix metalloproteinases, and complement cascade/hemoglobin toxicity are identified as major edema-promoting pathways in ICH.
- Experimental data support the role of these pathways in exacerbating brain swelling and neuronal damage.
- These pathways represent promising targets for novel therapeutic interventions.
Conclusions:
- Targeting the coagulation cascade, inflammatory response, and hemoglobin toxicity pathways offers potential for developing new ICH therapies.
- Further research into these molecular mechanisms is crucial for advancing ICH treatment.
- Pharmaceutical targeting of these pathways could reduce cerebral edema and improve outcomes for ICH patients.
Abstract:
Intracerebral hemorrhage (ICH) is a devastating type of stroke with no effective therapies. Clinical advances in ICH treatment are limited by an incomplete understanding of the molecular mechanisms responsible for secondary injury and poor outcome. Increasing evidence suggests that cerebral edema is a major contributor to secondary injury and poor outcome in ICH. ICH activates specific signaling pathways that promote edema and damage neuronal tissue. By increasing our understanding of these pathways, we may be able to target them pharmaceutically to reduce edema in ICH patients. In this review, we focus on three major signaling pathways that promote edema after ICH: (1) the coagulation cascade and thrombin, (2) the inflammatory response and matrix metalloproteinases, and (3) the complement cascade and hemoglobin toxicity. We will describe the experimental evidence that confirms these pathways promote edema in ICH, discuss potential targets for new therapies, and comment on important directions for future research.
Related Concept Videos
Cerebral Edema ll: Pathophysiology
Cerebral Edema l: Introduction
Cytotoxic Edema: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Bacterial Meningitis II: Pathophysiology
Increased Intracranial Pressure ll: Pathophysiology

